Market Research Future (MRFR) Announces the Publication of its Research Report—Global Hemoglobinopathies Market, 2019–2025. Hemoglobinopathies Market Show Industry Size, Share, Trend, Growth, Future Predictions Regional Analysis with Worldwide Topmost Players Forecast And Foreseen by 2025
Hemoglobinopathies Market Highlights:
Hemoglobinopathies are also known as hemoglobinopathy. It is the medical term referred to the group of blood disorders and diseases that affect red blood cells. Hemoglobinopathies are inherited single-gene disorders, and in most cases, it is inherited as autosomal co-dominant traits.
The global hemoglobinopathies market is estimated to drive the market growth owing to the rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E. Also, a low level of hygiene and poor healthcare infrastructure are some key factors attributing to the growth of the target population in low-income regions such as South-East Asia, the Mediterranean basin, and Africa. However, the lack of treatment and diagnosis awareness may hamper market growth over the forecast period.
Get Free Sample Report at https://www.marketresearchfuture.com/sample_request/8098
Hemoglobinopathies Market Key Players
Some of the key players in the global hemoglobinopathies market are Sanofi, Sangamo Therapeutics Inc., Global Blood Therapeutics, Bluebird Bio Inc., Emmaus Life Sciences Inc., Prolong Pharmaceuticals, Celgene Corporation, Alnylam Pharmaceuticals, Gamida Cell, Acceleron Pharma, Mast Therapeutic, HemaQuest Pharmaceuticals, and Invenux.
Hemoglobinopathies Market Segmentation
The global hemoglobinopathies market is segmented based on type, treatment, test types, and region.
The global market for hemoglobinopathies, by type, is segmented into thalassemia, sickle cell disease, and other Hb variants diseases. The thalassemia segment is further classified as alpha thalassemia and beta thalassemia. The sickle cell disease segment is expected to hold the largest market share of the hemoglobinopathies market owing to the presence of strong product pipelines such as LentiGlobin and rising prevalence of sickle cell disease.
Based on treatment, the market is classified into stem-cell transplantation, blood transfusions, analgesics, antibiotics, ACE inhibitors, and hydroxyurea. Also, based on treatment, the blood transfusion segment holds the largest market share owing to significant success rate and increasing adoption of this treatment option.
The market by end user, has been segmented into hospitals & clinics, diagnostics laboratories, and others.
On the basis of region, the global hemoglobinopathies market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Hemoglobinopathies Market Regional Analysis
The global hemoglobinopathies market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hemoglobinopathies market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.
The European hemoglobinopathies market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The hemoglobinopathies market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The hemoglobinopathies market in the Middle East & Africa has been segmented into the Middle East and Africa.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables And Figures At https://www.marketresearchfuture.com/reports/hemoglobinopathies-market-8098
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312